中文
English
한국어
日本語
Español
Français
Русский
| 카탈로그 번호 | DS856018 |
|---|---|
| 설명 |
Afasevikumab ELISA Kit (DS856018) — Quantitative sandwich ELISA for Afasevikumab. Sample: Plasma, Serum. Range: 0.31-5 μg/mL. Sensitivity: 0.156 μg/ml.
Highlights
|
| 샘플 유형 | Plasma, Serum |
| 민감도 | 0.156 μg/ml |
| 범위 | 0.31-5 μg/mL |
| 등록번호 | Q16552 & Q96PD4 |
| 응용 분야 | ELISA |
| 검출 방법 | Colorimetric |
| 분석 유형 | Quantitative |
| 회수율 | 80-120% |
| 배송 | 2-8 ℃ |
| 안정성 및 저장 | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| 사양 | Afasevikumab |
| 대체 이름 | MCAF-5352A, MCAF5352A, NI-1401, RG-7624, RG7624, RO5553110, 1589503-30-9 |
| 배경 | Afasevikumab, also known as RG7624, is a human antibody inhibitor for human interleukin 17A (IL17A) and interleukin 17F (IL17F). This drug was developed by Genentech and has been investigated in the study of the treatment of inflammation diseases like autoimmune disorders. In 2013, Genentech completed a phase Ib study for the treatment of autoimmune disorders in Canada. However, it had been discontinued in 2015. In 2016, researchers used afasevikumab to conduct a phase I clinical trials for the treatment of inflammation in USA with no specified. |
| 참고사항 | For Research Use Only. |
Standard Curve of Afasevikumab ELISA Kit
+86-027-65523339
중국 우한시 심둔사로 666번지 C동, 우한, 430206
